Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment

A high recurrence rate of non-Hodgkin's lymphoma (NHL) following chimeric antigen receptor T (CAR T) cell treatment remains a bottleneck, and immunosuppressive tumor microenvironment (TME) compromising CAR T cell efficacy in NHL is the primary cause of relapse. Accordingly, modifying the struct...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Yingqi, Liao, Peiyun, Wang, Hao, Chen, Jianyu, Hu, Yuxing, Hu, Rong, Zhang, Honghao, Li, Zhongwei, Cao, Manxiong, Yang, Yulu, Li, Meifang, Xie, Xiaoling, Li, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539696/
https://www.ncbi.nlm.nih.gov/pubmed/37781520
http://dx.doi.org/10.7150/ijbs.86632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539696/
https://www.ncbi.nlm.nih.gov/pubmed/37781520
http://dx.doi.org/10.7150/ijbs.86632

Ejemplares similares